MedPath
HSA Approval

B-MYCIN CREAM

SIN14386P

B-MYCIN CREAM

B-MYCIN CREAM

July 25, 2013

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D07CC01

betamethasone and antibiotics

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. INDUSTRIES (M) SDN. BHD.

Active Ingredients

Gentamicin Sulfate eqv Gentamicin

1.0mg/g

Gentamicin

Betamethasone Dipropionate Micronized 0.643mg eqv Betamethasone

0.5mg/g

Betamethasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

B-MYCIN CREAM - HSA Approval | MedPath